Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies

By Hoare C.M.   DeBouck P.   Wiseman A.  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 273-275

Elsevier

Access to resources Recommend Favorite

Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease

By Aasted B.   Alexandersen S.   Christensen J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1158-1165

Elsevier

Access to resources Recommend Favorite

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite

A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2

By Wong H.-T.   Cheng S.C.-S.   Sin F.W.-Y.   Chan E.W.-C.   Sheng Z.-T.   Xie Y.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2641-2647

Elsevier

Access to resources Recommend Favorite

Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein

By Langeveld J.P.M.   Kamstrup S.   Uttenthal A.   Strandbygaard B.   Vela C.   Dalsgaard K.   Beekman N.J.C.M.   Meloen R.H.   Casal J.I.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1033-1037

Elsevier

Access to resources Recommend Favorite